Bioconjugates, ADCs & Chemistry - Abzena

Abzena is a fully integrated biologics, bioconjugates & ADC CDMO + CRO

Abzena empowers leading pharma and biotech companies worldwide with seamless, end-to-end solutions for complex biologics and bioconjugates as a fully integrated CDMO + CRO. Let's work together to keep moving medicine forward.

Why Abzena? Download Brochure

For over 20 years, Abzena has provided end-to-end, integrated biologics development services and solutions to biopharmaceutical and biotech companies worldwide. Our unique approach enables us to be far more than a traditional Contract Development & Manufacturing Organization (CDMO). Abzena’s capabilities range from antibody discovery and engineering to analytical and cell line development into clinical through commercial manufacturing of drug substance. We ensure quality and regulatory compliance at every stage of the process while accelerating the development and manufacturing of complex biologics, bioconjugates and ADCs. Abzena is built on a foundation of values for scientific innovation and operational ‘quality excellence‘ to ultimately make medicines more accessible to patients in need around the world.

Contact us to accelerate your development journey.

Contact Us

The Leading Biologic and Bioconjugate CDMO + CRO

Taking the decision to work with a biologics CDMO partner is challenging, and amongst the most crucial early decisions you will make on your molecule’s development. Abzena are ready to work together with you to de-risk and streamline the development and manufacture of your novel treatments such as ADCs, AOCs and RDCs so that you can rapidly bridge from discovery through commercial launch.

Contact Us

Why Abzena?

We offer a uniquely collaborative, personalized, and transparent partnership differentiated by our mission to keep moving medicine forward and our values. Leverage the insights gained from over 20 years of experience, and multiple decades of scientific knowledge across our team today.

We offer best-in-class biologics, bioconjugates and ADC CDMO + CRO services along with a highly detailed and personalized experience. Contact us today to find out more about our expanding ADC capabilities.

Contact Us

Extensive R&D capabilities with over 20 years of biologics, bioconjugates, & ADC CDMO experience

From biologics design to ADC developability, through to commercial manufacturing, Abzena offer integrated contract research, development, and manufacturing services for many of the leading pharma and biotech customers. Our scientific experts at our locations in Cambridge UK, Bristol and San Diego USA have experience working with hundreds of molecules across all stages of the drug development process.

Our Locations

ThioBridge®: Antibody Drug Conjugation (ADC) Platform Technology

Enhance your ADC development with our ThioBridge® conjugation platform technology. ThioBridge® has been developed to overcome many of the issues seen in existing technologies. It gives our customers ADCs improved stability, potency, and efficacy.

Explore ThioBridge®

Our Offering

ADC & Bioconjugation Services

Abzena has over 20 years of expertise in identifying and mapping the appropriate design space for the development of your complex antibody-drug conjugates (ADCs).

Through our developability assessments, we identify and de-risk your clinical candidates for development, ensuring that your timescales are met.

Bioconjugates & ADC Services
Bioconjugate Discovery & Design Bioconjugate Development Linker Payload Process Development & Optimization Bioconjugate Clinical Through Commercial cGMP Manufacturing Antibody-Drug Conjugate Manufacturing Analytical Method Development & Validation

Integrated Biologics

Abzena is a leading, integrated biologics CDMO + CRO. We use our scientific expertise and track record to accelerate your path to the market for mammalian and bioconjugate modalities. Our advanced service offering and technologies support biologics drug development, and the move from candidate selection to clinical use or commercialization.

Antibody Discovery Antibody Engineering Immunogenicity Assays Antibody Development Analytics & Bioassays Mammalian Cell Line Development Formulation Development Process Development & Optimization End-to-End Clinical Through Commercial cGMP Biologics Manufacturing Technology Transfer

Latest Abzena News & Insights

Blog

Part 1 of 3: The Importance of Developability Assessments – What is the critical role of developability assessments for guiding the next generation of drugs?

Read More

Articles

Contract Pharma: Bioprocessing Trends – Demonstrating bioprocessing comparability in the modern analytical age

Read More

News

Abzena Recognized as a Market-Leading Antibody-Drug Conjugate CDMO in Frost & Sullivan Radar Report

Read More